Test and Monitor Mesothelioma: Mesomark Assay

The Mesomark Assay works as an in vitro test to monitor and potentially diagnose Mesothelioma. Developed by Fujirebio Diagnostics and approved in late January 2007 by the FDA, it works by measuring levels of soluble mesothelin-related proteins (SMRPs) released by diseased mesothelioma cells.

The SMRP levels correlate directly with tumor volume thus permitting less invasive monitoring and improved assessment of treatment response. In the future, the test may be used as an early detection measure as evidenced by recently sponsored tests by the Early Detection Research Network of the National Cancer Institute

Use the list below to navigate through the Mesothelioma Treatment section and learn more.

If you or someone you love has been affected by Mesothelioma, now is the time to seek help. Fill out the form below and you can receive a FREE case evaluation from the experienced Mesothelioma lawyers at Weitz & Luxenberg.